share_log

HC Wainwright & Co. Reiterates Buy on Can Fite Biofarma, Maintains $18 Price Target

Benzinga ·  May 10 01:47

HC Wainwright & Co. analyst Vernon Bernardino reiterates Can Fite Biofarma (AMEX:CANF) with a Buy and maintains $18 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment